Delivery Order SPE2DB22D2005-SPE2DB24FJRE7

Award Date 8/12/24
Potential Completion Date 8/13/24
Potential Value $7.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award to Amerisourcebergen Drug Corporation is for the delivery of 4,565,913,695 units of ondansetron ODT 4 mg tablets in 30-count packages. The $4,375.98 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a key customer of Amerisourcebergen's federal contracting activities. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with the DLA Troop Support Medical through December 2025, under...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the delivery of 4,565,047,457 units of the prescription medication Ondansetron ODT 4 mg tablets. The $1,251.66 firm fixed-price contract was awarded on July 1, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 2, 2024. This appears to be a delivery order under...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,751,394 units of Ondansetron ODT 4 mg tablets. The contract has a firm fixed price of $5,976.49 and a completion date of September 11, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division was issued by the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The $1,068.42 fixed-price delivery order is for the supply of 4,564,731,173 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet in 30-count bottles. The contract has a completion date of May 29, 2024 and was awarded on May 28, 2024. This award is part of a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,728,753 units of Ondansetron ODT 8 mg tablets. The $3,297.64 contract has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under an indefinite delivery contract (IDC) valued up...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,820,315 units of 4 mg Ondansetron Orally Disintegrating Tablets in 30-count packages. The $1,284.83 contract has a firm fixed price and was awarded on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 7, 2024. The contract is a Delivery Order placed under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,249,283 units of the pharmaceutical product Ondansetron ODT 4 mg Tablet 30s. The award, valued at $6,719.95, has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,564,125,413 units of the prescription drug Ondansetron ODT 8mg Tablet. The contract, valued at $1,189.99, has an ultimate completion date of April 1, 2024. As the prime contractor, Amerisourcebergen Drug Corp will deliver these pharmaceutical products from its Corporate Office in Conshohocken, Pennsylvania to support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of 4,564,331,556 units of Ondansetron ODT 4 mg Tablets in 30-count packages. The $6,620.80 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), with a completion date of April 22, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,255,117 units of Ondansetron ODT 4 mg tablets. The firm-fixed-price contract has a ceiling value of $3,609.81 and a completion date of February 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRE7
    Delivery Order

This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,426,593 units of Ondansetron ODT 4 mg tablets in 30-count packages. The $7,658.27 firm fixed price award was made by the Defense Logistics Agency (DLA) and has an ultimate completion date of August 13, 2024. The contract is not a set-aside and is a delivery order issued under DLA's broader medical supplies and pharmaceutical Indefinite Delivery Contract (IDC), which has a potential value of up to $999,999,999 through December 2025. As a major pharmaceutical distributor, Amerisourcebergen provides a wide range of critical medications and medical supplies to support military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide.

Generated 11/11/24, 9:28 AM